Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series
Bowel obstruction associated with immunotherapy response may represent a rare treatment-related complication in dMMR CC. Clinicians must recognise this safety signal and share experience to maintain patient safety.
Authors
- Emily Linda Alouani (ORCID: https://orcid.org/0000-0002-2303-118X)
- Alice C. Westwood (ORCID: https://orcid.org/0000-0002-8697-9621)
- F. Pietrantonio
- James R. Platt (ORCID: https://orcid.org/0000-0003-0974-456X)
- Julien Taı̈eb (ORCID: https://orcid.org/0000-0002-9955-4753)
- Kai‐Keen Shiu (ORCID: https://orcid.org/0000-0001-6202-9640)
- James Glasbey (ORCID: https://orcid.org/0000-0001-7688-5018)
- Nicholas P. West (ORCID: https://orcid.org/0000-0002-0346-6709)
- Jenny F. Seligmann (ORCID: https://orcid.org/0000-0003-4379-6005)
- Sara Lonardi (ORCID: https://orcid.org/0000-0002-7593-8138)
- Damian Tolan (ORCID: https://orcid.org/0000-0001-9895-9874)
- Dominik Paul Modest (ORCID: https://orcid.org/0000-0002-6853-0599)
- Juliette Palle
- Jacqueline Allotey
- R. Intini
- Samuel Lihan (ORCID: https://orcid.org/0000-0003-2534-6350)
- Christopher J.M. Williams (ORCID: https://orcid.org/0000-0002-1574-653X)
- Astrid Schulze
- G. Mazzoli
- K Riyad
- Anna Maria Militello
Institutions
- Twitter (United States) (US)
- University of Leeds (GB)
- University College London Hospitals NHS Foundation Trust (GB)
- Université Paris Cité (FR)
- Heidelberg University (DE)
- Leeds Teaching Hospitals NHS Trust (GB)
- Hôpital Beaujon (FR)
- Aberdeen Royal Infirmary (GB)
- St James's University Hospital (GB)
- Humboldt-Universität zu Berlin (DE)
- NHS Grampian (GB)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Européen Georges-Pompidou (FR)
- German Cancer Society (DE)
- Hôpital Européen (FR)
- Istituto Oncologico Veneto (IT)
- Hôpital Rangueil (FR)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- University College London (GB)
Publication Details
- Journal
- ESMO Open
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.esmoop.2024.103698
- Citations
- 14
- Primary Topic
- Colorectal and Anal Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 8.02
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Celgene
- BeiGene
- Incyte
- Seagen
- Cancer Research UK
- National Institute for Health and Care Research
- Daiichi-Sankyo
- Astellas Pharma
- Servier
- Ipsen
- Genentech